Potassium orotate, tablets 500 mg 20 pcs

– In complex therapy as an adjunctive agent: In diseases of the liver and biliary tract caused by acute and chronic intoxications (except for organic lesions of the liver and biliary tract);

– In the consequences of malnutrition in children (alimentary and alimentary-infectious hypotrophy);

– in convalescence period after diseases;

– in chronic physical overexertion.

Indications

– In complex therapy as an adjuvant: for diseases of the liver and biliary tract caused by acute and chronic intoxications (with the exception of organic lesions of the liver and biliary tract);

– with the consequences of malnutrition in children (nutritional and nutritional-infectious malnutrition);

– during the period of recovery after illnesses;

– with chronic physical overstrain.

Pharmacological effect

Metabolic agent

Special instructions

During the treatment period, it is advisable to follow a diet.

Impact on the ability to drive vehicles. Wed and fur.:

The drug does not cause drowsiness and reduce the speed of psychomotor reactions

Active ingredient

Orotic acid

Composition

For one tablet

Active ingredient:

Potassium orotate -500.0 mg/

Excipients:

lactose monohydrate – 165.0 mg,

potato starch – 55.0 mg,

povidone K-17 – 22.5 mg,

calcium stearate – 7.5 mg.

Pregnancy

With caution.

Contraindications

Hypersensitivity to the components of the drug; acute and chronic organic liver damage (including cirrhosis of the liver); ascites (accumulation of fluid in the abdominal cavity); urolithiasis; renal failure; children under 3 years of age.

With caution:

Pregnancy and lactation period.

Side Effects

Potassium orotate is generally well tolerated. In some cases, allergic skin reactions may occur, which disappear after interruption of treatment.

Potassium orotate may also cause mild digestive upset (nausea, vomiting, diarrhea). When used in high doses on the background of a low-protein diet, liver dystrophy may develop.

If side effects occur, consult your doctor.

Interaction

Astringents and coating agents may slightly reduce the absorption of potassium orotate in the gastrointestinal tract. It makes it difficult to absorb iron, tetracycline, and sodium fluoride (the interval between taking the drug is at least 2-3 hours). Oral contraceptives, diuretics, muscle relaxants, glucocorticoids, insulin reduce the effect of the drug.

Overdose

There are no data on overdose.

Recommendations for use

Should be taken orally 1 hour before meals or 4 hours after meals.

Adults: 250-500 mg 2-3 times a day. The course of treatment lasts on average 20-30 days. If necessary, treatment can be repeated after 1 month. In exceptional cases, the dose for adults can be increased to 3 g per day.

Children – 10-20 mg/kg body weight per day, divided into 3-4 doses (for example, if the child’s body weight is 25 kg, then the allowed dose is from 25 x 10 = 250 mg (1/2 tablet) to 25 x 20 = 500 mg (1 tablet per day, divided into 3-4 doses). The course of treatment is 3-5 weeks.

If symptoms persist, consult your doctor.

Storage conditions

In a dry place at a temperature not exceeding 25 ° C in the manufacturer’s packaging.

Keep out of the reach of children.

Shelf life

4 years. After the expiration date indicated on the package, do not use.

Manufacturer

Irbitsky Chemical Plant, Russia